Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 49.4B | 57.4B | 44.3B | 45.9B |
Cost of revenue | 3.6B | 4.3B | 3.2B | 2.8B |
Gross profit | 45.8B | 53.1B | 41.2B | 43.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 14.4B | 16.8B | 13.1B | 15.9B |
Non operating interest income | ||||
Income | 1M | 2M | 1M | 1M |
Expense | 18M | 20M | 19M | 20M |
Other income expense | — | — | — | — |
Pretax income | 13.8B | 17.5B | 13.2B | 15.9B |
Tax provision | 1.9B | 5.3B | 4.0B | 4.7B |
Net income | 11.9B | 12.2B | 9.1B | 11.2B |
Basic EPS | — | — | — | 7.5 |
Diluted EPS | — | — | — | 7.5 |
Basic average shares | — | — | — | 243.6B |
Diluted average shares | — | — | — | 243.6B |
EBITDA | 14.4B | 16.8B | 13.1B | 16.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | -47M | -27M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |